You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 15, October 21, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Statistics and Research Methods
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corticosteroid Therapy for Severe Sepsis and Septic Shock

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The systematic review by Dr Annane and colleagues1 summarized the results of 22 clinical trials investigating corticosteroid therapy in sepsis. The review suggested that prolonged low-dose corticosteroid therapy (≥5 days, ≤300 mg/d of hydrocortisone or equivalent) decreases mortality and recommended treating adult patients with vasopressor-dependent septic shock. However, we believe that these recommendations are weakened by possible publication bias and by the relationship between severity of illness and the treatment effect of corticosteroids.

The review stated that "the funnel plot did not suggest evidence for publication bias."1 However, in a recent systematic review of corticosteroids in sepsis,2 we demonstrated publication bias within the group of trials investigating prolonged low-dose corticosteroids using an Egger regression test3 and a funnel plot. Therefore, we recommend performing similar analyses to examine the 12 trials investigating prolonged low-dose corticosteroids included in this review. Findings consistent with publication bias would imply that . . . [Full Text of this Article]

Peter C. Minneci, MD
minneci@email.chop.edu
Department of Surgery

Katherine J. Deans, MD
Department of Surgery
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

Charles Natanson, MD
Critical Care Medicine Department
National Institutes of Health
Bethesda, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Djillali Annane, Eric Bellissant, Pierre-Edouard Bollaert, Josef Briegel, Marco Confalonieri, Raffaele De Gaudio, Didier Keh, Yizhak Kupfer, Michael Oppert, and G. Umberto Meduri
JAMA. 2009;301(22):2362-2375.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Corticosteroid Therapy for Severe Sepsis and Septic Shock
Rafael Barberena Moraes and Mauro Antonio Czepielewski
JAMA. 2009;302(15):1643-1644.
EXTRACT | FULL TEXT  

Corticosteroid Therapy for Severe Sepsis and Septic Shock—Reply
Djillali Annane
JAMA. 2009;302(15):1644-1645.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.